BACKGROUND: We previously identified a number of genes which were methylated significantly more frequently in the tumor compared to the non-cancerous lung tissues from non-small cell lung cancer (NSCLC) patients. Detection of methylation profiles of genes in NSCLC could provide insight into differential pathways to malignancy and lead to strategies for better treatment of individuals with NSCLC. METHODS: We determined the DNA methylation status of 27 genes using quantitative MethyLight assays in lung tumor samples from 117 clinically well-characterized NSCLC patients. RESULTS: Hypermethylation was detected in one of more of the genes in 106 (91%) of 117 cases and was detected at high levels (percentage methylation reference (PMR)> or =4%) in 79% of NSCLC cases. Methylation of APC, CCND2, KCNH5 and, RUNX was significantly more frequent in adenocarcinomas compared to squamous cell carcinomas (SCC), while methylation of CDKN2A was more common in SCC. Hypermethylation of KCNH5, KCNH8, and RARB was more frequent in females compared to males. Hypermethylation of APC and CCND2 was inversely associated with proliferation score assessed by Ki-67 level. CONCLUSIONS: Our findings of differential gene hypermethylation frequencies in tumor tissues from patients with adenocarcinoma or squamous cell cancers and in females compared to males suggests that further investigation is warranted in order to more fully understand the potential disparate pathways and/or risk factors for NSCLC associated with histologic type and gender. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
BACKGROUND: We previously identified a number of genes which were methylated significantly more frequently in the tumor compared to the non-cancerous lung tissues from non-small cell lung cancer (NSCLC) patients. Detection of methylation profiles of genes in NSCLC could provide insight into differential pathways to malignancy and lead to strategies for better treatment of individuals with NSCLC. METHODS: We determined the DNA methylation status of 27 genes using quantitative MethyLight assays in lung tumor samples from 117 clinically well-characterized NSCLCpatients. RESULTS: Hypermethylation was detected in one of more of the genes in 106 (91%) of 117 cases and was detected at high levels (percentage methylation reference (PMR)> or =4%) in 79% of NSCLC cases. Methylation of APC, CCND2, KCNH5 and, RUNX was significantly more frequent in adenocarcinomas compared to squamous cell carcinomas (SCC), while methylation of CDKN2A was more common in SCC. Hypermethylation of KCNH5, KCNH8, and RARB was more frequent in females compared to males. Hypermethylation of APC and CCND2 was inversely associated with proliferation score assessed by Ki-67 level. CONCLUSIONS: Our findings of differential gene hypermethylation frequencies in tumor tissues from patients with adenocarcinoma or squamous cell cancers and in females compared to males suggests that further investigation is warranted in order to more fully understand the potential disparate pathways and/or risk factors for NSCLC associated with histologic type and gender. Copyright 2009 Elsevier Ireland Ltd. All rights reserved.
Authors: E B Kuznetsova; T V Kekeeva; S S Larin; V V Zemliakova; O V Babenko; M V Nemtsova; D V Zaletaev; V V Strel'nikov Journal: Mol Biol (Mosk) Date: 2007 Jul-Aug
Authors: Heather A Wakelee; Wei Wang; Joan H Schiller; Corey J Langer; Alan B Sandler; Chandra P Belani; David H Johnson Journal: J Thorac Oncol Date: 2006-06 Impact factor: 15.609
Authors: Qinghua Feng; Stephen E Hawes; Joshua E Stern; Linda Wiens; Hiep Lu; Zhao Ming Dong; C Diana Jordan; Nancy B Kiviat; Hubert Vesselle Journal: Cancer Epidemiol Biomarkers Prev Date: 2008-03 Impact factor: 4.254
Authors: Neal D Freedman; Michael F Leitzmann; Albert R Hollenbeck; Arthur Schatzkin; Christian C Abnet Journal: Lancet Oncol Date: 2008-06-13 Impact factor: 41.316
Authors: Yu-An Zhang; Xiaotu Ma; Adwait Sathe; Junya Fujimoto; Ignacio Wistuba; Stephen Lam; Yasushi Yatabe; Yi-Wei Wang; Victor Stastny; Boning Gao; Jill E Larsen; Luc Girard; Xiaoyun Liu; Kai Song; Carmen Behrens; Neda Kalhor; Yang Xie; Michael Q Zhang; John D Minna; Adi F Gazdar Journal: J Thorac Oncol Date: 2015-12-25 Impact factor: 15.609
Authors: Ana I Robles; Eri Arai; Ewy A Mathé; Hirokazu Okayama; Aaron J Schetter; Derek Brown; David Petersen; Elise D Bowman; Rintaro Noro; Judith A Welsh; Daniel C Edelman; Holly S Stevenson; Yonghong Wang; Naoto Tsuchiya; Takashi Kohno; Vidar Skaug; Steen Mollerup; Aage Haugen; Paul S Meltzer; Jun Yokota; Yae Kanai; Curtis C Harris Journal: J Thorac Oncol Date: 2015-07 Impact factor: 15.609
Authors: Laura Millares; Mireia Serra; Felipe Andreo; Jose Sanz-Santos; Concepción Montón; Carles Grimau; Miguel Gallego; Laia Setó; Neus Combalia; Mariona Llatjos; Rosa Escoda; Eva Castellà; Eduard Monsó Journal: Clin Exp Metastasis Date: 2015-06-29 Impact factor: 5.150
Authors: Maria N Timofeeva; Rayjean J Hung; Thorunn Rafnar; David C Christiani; John K Field; Heike Bickeböller; Angela Risch; James D McKay; Yufei Wang; Juncheng Dai; Valerie Gaborieau; John McLaughlin; Darren Brenner; Steven A Narod; Neil E Caporaso; Demetrius Albanes; Michael Thun; Timothy Eisen; H-Erich Wichmann; Albert Rosenberger; Younghun Han; Wei Chen; Dakai Zhu; Margaret Spitz; Xifeng Wu; Mala Pande; Yang Zhao; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Hans E Krokan; Maiken Elvestad Gabrielsen; Frank Skorpen; Lars Vatten; Inger Njølstad; Chu Chen; Gary Goodman; Mark Lathrop; Simone Benhamou; Tõnu Vooder; Kristjan Välk; Mari Nelis; Andres Metspalu; Olaide Raji; Ying Chen; John Gosney; Triantafillos Liloglou; Thomas Muley; Hendrik Dienemann; Gudmar Thorleifsson; Hongbing Shen; Kari Stefansson; Paul Brennan; Christopher I Amos; Richard Houlston; Maria Teresa Landi Journal: Hum Mol Genet Date: 2012-08-16 Impact factor: 6.150
Authors: Alexander Salskov; Stephen E Hawes; Joshua E Stern; Qinghua Feng; C Diana Jordan; Linda Wiens; Janet Rasey; Hiep Lu; Nancy B Kiviat; Hubert Vesselle Journal: J Oncol Date: 2011-03-28 Impact factor: 4.375